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INTRODUCTION
The incidence of infection in cardiac surgery remains
a potential cause of morbidity and mortality and the
most important step in the management of this problem
is prevention and this is best done by identifying the risk
factors. Diabetes mellitus is an independent predictor of
morbidity and/or mortality in patients undergoing coro-
nary artery bypass grafting (CABG)(1). However, there is
a growing body of clinical and experimental evidence
that diabetes increases the risk of infections and may
actually be a causal factor in the development of these
infections also in patients undergoing other cardiac
surgery procedures. The severity of infections may
range from minor, superficial wound infection to fulmi-
nate mediastinitis with involvement of the sternum,
heart and great vessels (2, 3) but also lung infections
and urinary tract infections. The sternum is the most
common infection site, it also accounted for >70% cas-
es of severe infection. The most commonly isolated or-
ganism at the sternal site is methicillin sensitive Staphy-
lococcus epidermidis followed by methicillin resistant
Staphylococcus aureus. We hypothesized that intensive
pherioperative hyperglycemia control by intravenous in-
sulin infusion reduces postoperative infections in all pa-
tients undergoing open heart surgical procedures.
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ABSTRACT: Background: Diabetes mellitus increases the risk of infections in patients undergo-
ing cardiac surgery. We hypothesized that intensive perioperative hyperglycemia control by in-
travenous insulin infusion reduces postoperative infections in all patients undergoing open heart
surgical procedures.
Methods: Sixty diabetics patients who underwent CABG operation (Group 1) were compared
with fifty-five patients who underwent other cardiac surgery (Group 2) between January 2004
and March 2005. A continuous infusion of insulin was used in all these patients.
Results: There were no 30-day mortalities in either group. There was no difference in the inci-
dence of infections between the two groups: in Group 1, 3 (5%) patients were diagnosed to have
postoperative infection (superficial sternal wound infections in 1 (1.66%) and lung infection in 2
(3.33%) patients); postoperative infection occurred in only 2 patients (3.63%) in Group 2, 1 su-
perficial sternal wound infections (1.81%) and 1 lung infection (1.81%).
Conclusions: Our analysis indicates that continuous intravenous insulin infusion improves out-
come and reduces postoperative infections in patients undergoing CABG as well as those un-
dergoing other cardiac surgery procedures. (Heart International 2006; 2: 49-53)
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SUBJECTS AND METHODS
Patients with diabetes mellitus undergoing primary
open heart surgery between January 2004 and March
2005 at St. Andrea Hospital were included in the study.
The exclusion criteria were reoperations and history of
allergy to penicillin/cephalosporins. Sixty diabetic pa-
tients who underwent CABG operation (Group 1) were
compared with fifty-five patients who underwent other
cardiac surgery (Group 2) in the same period. The pre-
operative base-line characteristics of the patients are
summarized in Table I. There were no changes in anti-
biotic protocols during this time and procedures were
performed by the same surgical group. On the day prior
to surgery and on the day of surgery patients were ad-
vised to take a bath with 4% chlorhexidine which was
applied to the whole body and retained for at least 5
minutes before taking a bath. Operative site was pre-
pared using 10% povidone-iodine scrub solution (Beta-
dine) for disinfection. In this one hundred fifteen pa-
tients we aimed to maintain the blood glucose levels pe-
rioperatively between 90-120 mg/dL. During the hospi-
tal stay, patients were evaluated daily preoperatively
and postoperatively from the third day onward. In addi-
tion, all these patients were seen by an endocrinologist
during their admission. The insulin-dependent diabetics
should receive their regular dose of insulin the evening
before the operative day. Insulin dose infusion starts in
operating room: 2-4 U/h is the rule during operation. In
the postoperative period the patients’ blood glucose
levels were prospectively monitored every 1 or 2 hours
through fingerstick or arterial line drop sample. A con-
tinuous infusion of insulin (50 IU of Actrapid HM in 50
mL of 0.9% sodium chloride) with the use of a pump
(Fresenius, Brezins, France) was started only if the
blood glucose level exceeded 120 mg/dL and the infu-
sion was adjusted to maintain the level at a value be-
tween 90 to 120 mg/dL. We didn’t use a precise proto-
col because the dose of insulin administered was ad-
justed according to patient’s compliance. Daily mean
blood glucose levels were then calculated by averaging
all glucose levels obtained clinically during the day of
operation and each of the first through third postopera-
tive days. Blood cultures were obtained whenever the
central body temperature exceeded 37.5°C. Patients
were then screened for postoperative infectious compli-
cations or readmission for the same reason. 
Definition of infectious complications
Definitions for deep and superficial sternal wound in-
fection followed the guidelines of the Centers for Dis-
ease Control and Prevention (4).
Deep sternal wound infection (DSWI): isolation of an
organism from culture of the mediastinal tissue or fluid,
visual evidence of mediastinitis, chest instability, or
fever  associated  with  the  presence  of  purulent
drainage. 
TABLE I - BASE-LINE CHARACTERISTICS OF THE PATIENTS
Group 1 Group 2 p value
(n = 60) (n = 55)
Age (years) 63.8 ± 1.3 68.2 ± 1.5 ns
Male-no.(%) 40 (66.6%) 37 (67.2%) ns
BMI (kg/m
2) 25.8 ± 4.7 26.1 ± 4.3 ns
Smoking-no.(%) 47 (78.3%) 42 (76.3%) ns
Hypertension-no. (%) 53 (88.3%) 47 (85.4%) ns
Renal failure-no. (%) 23 (38.3%) 20 (36.3%) ns
Admission glucose-no.(%):
> 110 mg/dL 23 (38.3%) 19 (34.5%) ns
> 200 mg/dL 7 (11.6%) 6 (10.9%) ns
Preoperative diabetic medication (%):
Insuline alone 30.8 29.5 ns
Oral hypoglycemic(s) alone 57.7 58.1 ns
Diet alone 5.4 4.8 ns
None 1.2 1.5 ns
BMI = body mass index; ns = not significantCapuano et al
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Superficial sternal wound infection (SSWI): when pu-
rulent discharge was not associated with involvement of
sternal or mediastinal tissues. 
RESULTS
Between January 2004 and March 2005 at St. Andrea
Hospital one hundred fifteen diabetics patients under-
went primary open heart surgery. Sixty diabetic patients
who underwent CABG operation (Group 1) were com-
pared with fifty-five patients who underwent other car-
diac surgery (Group 2) in the same period. The two
groups of patients were comparable with respect to
preoperative, intraoperative and postoperative vari-
ables. There were no significant differences with re-
spect to age, sex, body mass index; the majority of all
diabetic patients were on oral hypoglycemic agents; the
cardiac procedures performed in this diabetic cohort in-
cluded, for Group 1, 90% CABG on pump and 10%
CABG off pump and, for Group 2, 61% mitral valve re-
placement (MVR), 30% aortic valve replacement (AVR),
6% MVR + AVR and 3% Bentall technique (Tab. II).
Cross-clamp (81.3 ± 1.5 minutes Group 1 versus 85.4 ±
2.5 minutes Group 2; p=ns) and cardiopulmonary by-
pass time (90.4 ± 2.5 minutes Group 1 versus 98.2 ± 2.7
minutes Group 2; p=ns) were similar between groups
(Tab. III). Insulin dose infusion started in the operating
room and was adjusted based on serial glucose mea-
surements. Mean glucose levels of diabetic patients in
postoperative 1st day (116.5 ± 3 mg/dL Group 1 versus
114.4 ± 5 mg/dL Group 2) in postoperative 2nd day (117
± 5 mg/dL Group 1 versus 118 ± 7 mg/dL Group 2) and
in postoperative 3rd day (115 ± 2 mg/dL Group 1 versus
TABLE II - CARDIAC SURGICAL PROCEDURES CARRIED OUT
IN GROUP 1 AND GROUP 2
Group 1 (n = 60)
CABG on pump (%) 90
CABG off pump (%) 10
One IMA (%) 89
Two IMA (%) 11
Group 2 (n=55)up 2 (n=55)
MVR (%) 61
AVR (%) 30
MVR + AVR (%) 6
Bentall Technique (%) 3
CABG = coronary artery bypass grafting; IMA = internal mammary
artery; MVR = mitral valve replacement; AVR = aortic valve re-
placement
TABLE III - INTRAOPERATIVE VARIABLES
Group 1 Group 2 p value
(n = 60) (n = 55)
Mean CPB time (min) 90.4 ± 2.5  98.2 ± 2.7 ns
Mean aortic cross-clamp time (min) 81.3 ± 1.5 85.4 ± 2.5 ns
Operative status (%):
elective 94 96 ns
urgent 4 3 ns
emergent 2 1 ns
CPB = cardiopulmonary bypass; ns = not significant
TABLE IV - GLUCOSE LEVEL AFTER OPERATION
Group 1 Group 2 p value
(n = 60) (n = 55)
Postop 1st day (mg/dL) 116.5 ± 3 114.4 ± 5 ns
Postop 2nd day (mg/dL) 0.117 ± 5 0.118 ± 7 ns
Postop 3rd day (mg/dL) 0.115 ± 2 0.116 ± 4 ns
ns = not significantPerioperative hyperglycemia control
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116 ± 4 mg/dL Group 2) were also similar between
groups  (Tab.  IV).  No  cases  of  symptomatic  hypo-
glycemia occurred in either group of patients. There
were no 30-day mortalities in either group. In Group 1,
three (5%) patients were diagnosed to have postopera-
tive infection (SSWI in 1 (1.66%) and lung infection in 2
(3.33%) patients). Postoperative infection occurred in
only 2 patients (3.63%) in Group 2, 1 SSWI (1.81%) and
1 lung infection (1.81%) (Tab. V). Staphylococcus au-
reus was cultured in 3 patients (lung infections) and
Staphylococcus epidermidis in 2 patients (SSWI).
DISCUSSION
Diabetes is a well-known risk factor for perioperative
medical complications. Poor glucose control is a inde-
pendent risk factor for surgical site infections (5,6) in a
range of surgical procedures like cardiac surgery. Hy-
perglycemia impairs the function of complement and
antibodies, reducing the opsonic potential of these fac-
tors and impairing phagocytosis, further reducing barri-
ers to infection (7). These abnormalities develop when
blood glucose levels exceed 11 mmol/L and do improve
in vitro with glycemic control (8); so improving glucose
control can improve immunologic function and reduce
the incidence of infections (9). The findings of this in-
vestigation demonstrate that intensive perioperative hy-
perglycemia control by intravenous insulin infusion re-
duces postoperative infections in all patients undergo-
ing open heart surgical procedures. The perioperative
hyperglycemia control was implemented by nurses in
the surgical intensive care unit and warm and involved
routine consultation and follow-up by an endocrinolo-
gist. The mean glucose value the first three postopera-
tive days after open heart operation was found to be the
most important factor for wound infection. Aggressive
glucose  control  in  the  perioperative  period  can  be
achieved using a continuous intravenous insulin infu-
sion. Between January 2004 and March 2005 at St. An-
drea Hospital, the nursing staff monitored fingerstick or
arterial line drop of blood sample glucose measure-
ments and adjusted the infusion rate intended to main-
tain serum glucose between 90-120 mg/dL. In our study
we consecutively included all diabetic patients being
operated on, and follow-up was 100% complete. The
exclusion criteria were reoperations and history of aller-
gy to penicillin/cephalosporins. The personnel, equip-
ment, surgical techniques and use of prophylactic an-
tibiotics were similar throughout the study period. The
aim of our study was to find differences in infection inci-
dence in two group of diabetic patients treated with
continuous intravenous insulin infusion: Group 1 (n=60)
who underwent CABG operation and Group 2 (n=55)
who underwent other cardiac surgery in the same peri-
od. There was no difference in the incidence of infec-
tions between the two groups: in this study infection af-
ter heart surgery occurred in only 5 of 115 patients
(4.34%): 3 (5%) in Group 1 and 2 (3.63%) in group 2.
Staphylococcus aureus  was  the  most  common
pathogen isolated in patients with infection after car-
diac surgery, both in our study and in cases reported in
the literature (10). Reports of increased risk with use of
the internal mammary artery have differed and occa-
sionally conflict among institutions (11). Our experience
suggests that, in the diabetic patient population, peri-
operative hyperglycemia control may obviate also the
infectious  risk  of  bilateral  internal  mammary  artery
grafts. A balanced diet is also essential for the unevent-
ful postoperative metabolic status. Van-den-Berghe et
al recently reported that maintaining blood glucose lev-
els between 80 mg/dL and 110 mg/dL significantly re-
TABLE V - POSTOPERATIVE OUTCOMES
Group 1 Group 2 p value
(n = 60) (n = 55)
Death 0 0 ns
DSWI 0 0 ns
SSWI 1 (1.66%) 1 (1.81%) ns
Urinary tract infection 0 0 ns
Lung infection 2 (3.33%) 1 (1.81%) ns
DSWI = deep sternal wound infection; SSWI = superficial sternal wound infection; ns = not significantCapuano et al
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duced morbidity and mortality in a cohort of surgical in-
tensive care unit patients where 63% of the population
were postoperative cardiac surgery patients (12). We
urge surgeons and all concerned physicians not to ig-
nore the potentially harmful and costly effect of periop-
erative hyperglycemia in patients undergoing heart
surgery. In summary, our analysis indicates that contin-
uous intravenous insulin infusion improves outcome
and reduces postoperative infections in patients under-
going CABG as well as those undergoing other cardiac
surgery procedures.
Address for correspondence:
Fabio Capuano, MD
Via Flaminia, 1227
00188 Roma - Italy
capmd@katamail.com
REFERENCES
1. Salomon N, Page U, Okies J, Stephens J, Krause A,
Bigelow J. Diabetes mellitus and coronary artery bypass.
J Thorac Cardiovasc Surg 1983; 85: 264-71.
2. Vaska PL. Sternal wound infections (Review). AACN Clin
Issue Crit Care Nurs 1993; 4: 475-83.
3. Blanchard A, Hurni M, Ruchat P, Stumpe F, Fischer A,
Sadeghi H. Incidence of deep and superficial sternal in-
fection after open heart surgery. A ten years retrospective
study from 1981 to 1991. Eur J Cardiothorac Surg 1995;
20: 272-9.
4. Mangram AJ, Horan TC, Pearson ML, Silver LC, Jarvis
WR. Guideline for prevention of surgical site infection,
1999. Hospital Infection Control Practices Advisory Com-
mittee. Infect Control Hosp Epidemiol 1999; 20: 250-78.
5. Moro ML, Carrieri MP, Tozzi AE, Lana S, Greco D. Risk
factors for surgical wound infections in clean surgery: A
multicenter study. Italian PRINOS Study Group. Ann Ital
Chir 1996; 67: 13-9.
6. Zacharias AZ, Habib RH. Factors predisposing to median
sternotomy complications. Chest 1996; 110: 1173-8.
7. Black CT, Hennessey PJ, Andrassy RJ. Short-term hyper-
glycemia depresses immunity through nonenzymatic gly-
cosylation of circulating immunoglobulin. J Trauma 1990;
30: 830-2.
8. McMahon MM, Bistrian BR. Host defences and suscepti-
bility to infection in patients with diabetes mellitus. Infect
Dis Clin North Am 1995; 9: 1-9.
9. Allen DB, Maguire JJ, Mahdavian M, Wicke C, Marcocci
L, Scheuenstuhl H. Wound hypoxia and acidosis limit
neutrophil bacterial killing mechanisms. Arch Surg 1997;
132: 991-6.
10. Loop F, Lytle B, Cosgrove D. Sternal wound infection af-
ter isolated coronary artery bypass grafting. Early and
late mortality, morbidity and cost of care. Ann Thorac
Surg 1990; 49: 179-87.
11. Lust RM, Sun YS, Chitwood WR Jr. Internal mammary
artery use. Sternal revascularization and experimental in-
fection patterns. Circulation 1991; 84 (suppl 3): S285-9.
12. Van-der-Berghe G, Outers P. Intensive insulin therapy in
critically ill patients. N Engl J Med 2001; 19: 1359-67.